메뉴 건너뛰기




Volumn 6, Issue 3, 2006, Pages 169-175

Different effects of simvastatin and losartan on cytokine levels in coronary artery disease

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANGIOTENSIN 1 RECEPTOR ANTAGONIST; ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; COLONY STIMULATING FACTOR 1; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LOSARTAN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; NITRATE; SIMVASTATIN; TRANSFORMING GROWTH FACTOR BETA;

EID: 33745494141     PISSN: 11753277     EISSN: 11753277     Source Type: Journal    
DOI: 10.2165/00129784-200606030-00004     Document Type: Article
Times cited : (2)

References (36)
  • 1
    • 0027987849 scopus 로고
    • Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: The Scandinavian Simvastatin Survival Study (4S)
    • Scandinavian Simvastatin Survival Study Group. Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S). Lancet 1994; 344: 1383-9
    • (1994) Lancet , vol.344 , pp. 1383-1389
  • 2
    • 0037031061 scopus 로고    scopus 로고
    • MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals; a randomised placebo-controlled trial
    • Heart Protection Study Collaborative Group. MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals; a randomised placebo-controlled trial. Lancet 2002; 360: 7-22
    • (2002) Lancet , vol.360 , pp. 7-22
  • 3
    • 0034603775 scopus 로고    scopus 로고
    • Inhibition of early atherogenesis by losartan in monkeys with diet-induced hypercholesterolemia
    • Strawn WB, Chappell MC, Dean RH, et al. Inhibition of early atherogenesis by losartan in monkeys with diet-induced hypercholesterolemia. Circulation 2000; 101: 1586-93
    • (2000) Circulation , vol.101 , pp. 1586-1593
    • Strawn, W.B.1    Chappell, M.C.2    Dean, R.H.3
  • 4
    • 0034711717 scopus 로고    scopus 로고
    • Important role of local angiotensin II activity mediated via type 1 receptor in the pathogenesis of cardiovascular inflammatory changes induced by chronic blockade of nitric oxide synthesis in rats
    • Usui M, Egashira K, Tomita H, et al. Important role of local angiotensin II activity mediated via type 1 receptor in the pathogenesis of cardiovascular inflammatory changes induced by chronic blockade of nitric oxide synthesis in rats. Circulation 2000; 101: 305-10
    • (2000) Circulation , vol.101 , pp. 305-310
    • Usui, M.1    Egashira, K.2    Tomita, H.3
  • 5
    • 8644277443 scopus 로고    scopus 로고
    • Effects of low-dose angiotensin II receptor blocker candesartan on cardiovascular events in patients
    • Kondo J, Sone T, Tsuboi H, et al. Effects of low-dose angiotensin II receptor blocker candesartan on cardiovascular events in patients. Am Heart J 2003; 146: E20
    • (2003) Am Heart J , vol.146
    • Kondo, J.1    Sone, T.2    Tsuboi, H.3
  • 6
    • 0030926821 scopus 로고    scopus 로고
    • Altered plasma levels of cytokines in patients with ischemic heart disease
    • Tashiro H, Shimokawa H, Yamamoto K, et al. Altered plasma levels of cytokines in patients with ischemic heart disease. Coron Artery Dis 1997; 8: 143-7
    • (1997) Coron Artery Dis , vol.8 , pp. 143-147
    • Tashiro, H.1    Shimokawa, H.2    Yamamoto, K.3
  • 7
    • 0033600543 scopus 로고    scopus 로고
    • Increased proinflammatory cytokines in patients with chronic stable angina and their reduction by aspirin
    • Ikonomidis I, Andreotti F, Economou E, et al. Increased proinflammatory cytokines in patients with chronic stable angina and their reduction by aspirin. Circulation 1999; 100: 793-8
    • (1999) Circulation , vol.100 , pp. 793-798
    • Ikonomidis, I.1    Andreotti, F.2    Economou, E.3
  • 8
    • 0036122383 scopus 로고    scopus 로고
    • Increased levels of monocyte-related cytokines in patients with unstable angina
    • Hojo Y, Ikeda U, Takahashi M, et al. Increased levels of monocyte-related cytokines in patients with unstable angina. Atherosclerosis 2002; 161: 403-8
    • (2002) Atherosclerosis , vol.161 , pp. 403-408
    • Hojo, Y.1    Ikeda, U.2    Takahashi, M.3
  • 9
    • 0035108994 scopus 로고    scopus 로고
    • Role of cytokines in the pathogenesis of restenosis after percutaneous transluminal coronary angioplasty
    • Tashiro H, Shimokawa H, Sadamatsu K, et al. Role of cytokines in the pathogenesis of restenosis after percutaneous transluminal coronary angioplasty. Coron Artery Dis 2001; 12: 107-13
    • (2001) Coron Artery Dis , vol.12 , pp. 107-113
    • Tashiro, H.1    Shimokawa, H.2    Sadamatsu, K.3
  • 10
    • 0034163470 scopus 로고    scopus 로고
    • Clinical significance of increased plasma concentration of macrophage colony-stimulating factor in patients with angina pectoris
    • Saitoh T, Kishida H, Tsukada Y, et al. Clinical significance of increased plasma concentration of macrophage colony-stimulating factor in patients with angina pectoris. J Am Coll Cardiol 2000; 35: 655-65
    • (2000) J Am Coll Cardiol , vol.35 , pp. 655-665
    • Saitoh, T.1    Kishida, H.2    Tsukada, Y.3
  • 11
    • 0036307946 scopus 로고    scopus 로고
    • Prognostic significance of plasma concentrations of transforming growth factor-β in patients with coronary artery disease
    • Tashiro H, Shimokawa H, Sadamatu K, et al. Prognostic significance of plasma concentrations of transforming growth factor-β in patients with coronary artery disease. Coron Artery Dis 2002; 13: 139-43
    • (2002) Coron Artery Dis , vol.13 , pp. 139-143
    • Tashiro, H.1    Shimokawa, H.2    Sadamatu, K.3
  • 12
    • 0030969425 scopus 로고    scopus 로고
    • Role of macrophage colony-stimulating factor in atherosclerosis: Studies of osteopetrotic mice
    • Qiao JH, Tripathi J, Mishra NK, et al. Role of macrophage colony-stimulating factor in atherosclerosis: studies of osteopetrotic mice. Am J Pathol 1997; 150: 1687-99
    • (1997) Am J Pathol , vol.150 , pp. 1687-1699
    • Qiao, J.H.1    Tripathi, J.2    Mishra, N.K.3
  • 13
    • 0031878224 scopus 로고    scopus 로고
    • Adenovirus-mediated gene transfer of macrophage colony stimulating factor to the arterial wall in vivo
    • Mozes G, Mohacsi T, Gloviczki P, et al. Adenovirus-mediated gene transfer of macrophage colony stimulating factor to the arterial wall in vivo. Arterioscler Thromb Vasc Biol 1998; 18: 1157-63
    • (1998) Arterioscler Thromb Vasc Biol , vol.18 , pp. 1157-1163
    • Mozes, G.1    Mohacsi, T.2    Gloviczki, P.3
  • 14
    • 0034821456 scopus 로고    scopus 로고
    • Long term treatment with enalapril reduces plasma concentrations of macrophage colony stimulating factor in patients with coronary artery disease
    • Sadamatsu K, Shimokawa H, Tashiro H, et al. Long term treatment with enalapril reduces plasma concentrations of macrophage colony stimulating factor in patients with coronary artery disease. Heart 2001; 86: 457-8
    • (2001) Heart , vol.86 , pp. 457-458
    • Sadamatsu, K.1    Shimokawa, H.2    Tashiro, H.3
  • 15
    • 0037246520 scopus 로고    scopus 로고
    • Inflammation in early atherogenesis: Impact of ACE inhibition
    • Caterina RD, Manes C. Inflammation in early atherogenesis: impact of ACE inhibition. Eur Heart J 2003; 5 Suppl. A: A15-24
    • (2003) Eur Heart J , vol.5 , Issue.SUPPL. A
    • Caterina, R.D.1    Manes, C.2
  • 16
    • 0032584177 scopus 로고    scopus 로고
    • Upregulation of endothelial nitric oxide synthase by HMG CoA reductase inhibitors
    • Laufs U, Fata VL, Plutzky J, et al. Upregulation of endothelial nitric oxide synthase by HMG CoA reductase inhibitors. Circulation 1998; 97: 1129-35
    • (1998) Circulation , vol.97 , pp. 1129-1135
    • Laufs, U.1    Fata, V.L.2    Plutzky, J.3
  • 17
    • 0029043048 scopus 로고
    • Nitric oxide inhibits macrophage-colony stimulating factor gene transcription in vascular endothelial cells
    • Peng HB, Rajavashisth TB, Libby P, et al. Nitric oxide inhibits macrophage-colony stimulating factor gene transcription in vascular endothelial cells. J Biol Chem 1995; 270: 17050-5
    • (1995) J Biol Chem , vol.270 , pp. 17050-17055
    • Peng, H.B.1    Rajavashisth, T.B.2    Libby, P.3
  • 18
    • 0035834818 scopus 로고    scopus 로고
    • Inhibition of transforming growth factor-β signaling accelerates atherosclerosis and induces an unstable plaque phenotype in mice
    • Mallat Z, Gojova A, Marchiol-Fournigault C, et al. Inhibition of transforming growth factor-β signaling accelerates atherosclerosis and induces an unstable plaque phenotype in mice. Circ Res 2001; 89: 930-4
    • (2001) Circ Res , vol.89 , pp. 930-934
    • Mallat, Z.1    Gojova, A.2    Marchiol-Fournigault, C.3
  • 19
    • 0036078307 scopus 로고    scopus 로고
    • Transforming growth factor-β mediates balance between inflammation and fibrosis during plaque progression
    • Lutgens E, Gijbels M, Smook M, et al. Transforming growth factor-β mediates balance between inflammation and fibrosis during plaque progression. Arterioscler Thromb Vasc Biol 2002; 22: 975-82
    • (2002) Arterioscler Thromb Vasc Biol , vol.22 , pp. 975-982
    • Lutgens, E.1    Gijbels, M.2    Smook, M.3
  • 20
    • 4744371004 scopus 로고    scopus 로고
    • Increased expression of transforming growth factor-β1 as a stabilizing factor in human atherosclerotic plaques
    • Cipollone F, Fazia M, Mincione G, et al. Increased expression of transforming growth factor-β1 as a stabilizing factor in human atherosclerotic plaques. Stroke 2004; 35: 2253-7
    • (2004) Stroke , vol.35 , pp. 2253-2257
    • Cipollone, F.1    Fazia, M.2    Mincione, G.3
  • 21
    • 0035177661 scopus 로고    scopus 로고
    • Role of endogenous angiotensin II in the increased expression of growth factors in vascular smooth muscle cells from spontaneously hypertensive rats
    • Satoh C, Fukuda N, Hu WY, et al. Role of endogenous angiotensin II in the increased expression of growth factors in vascular smooth muscle cells from spontaneously hypertensive rats. J Cardiovasc Pharmacol 2001; 37: 108-18
    • (2001) J Cardiovasc Pharmacol , vol.37 , pp. 108-118
    • Satoh, C.1    Fukuda, N.2    Hu, W.Y.3
  • 22
    • 0031814542 scopus 로고    scopus 로고
    • Early induction of transforming growth factor-β via angiotensin II type 1 receptors contributes to cardiac fibrosis induced by long-term blockade of nitric oxide synthesis in rats
    • Tomita H, Egashira K, Ohara Y, et al. Early induction of transforming growth factor-β via angiotensin II type 1 receptors contributes to cardiac fibrosis induced by long-term blockade of nitric oxide synthesis in rats. Hypertension 1998; 32: 273-9
    • (1998) Hypertension , vol.32 , pp. 273-279
    • Tomita, H.1    Egashira, K.2    Ohara, Y.3
  • 23
    • 0141792887 scopus 로고    scopus 로고
    • Effect of angiotensin II receptor blocker on plasma levels of TGF-β1 and interstitial fibrosis in hypertensive kidney transplant patients
    • El-Agroudy AE, Hassan NA, Foda MA, et al. Effect of angiotensin II receptor blocker on plasma levels of TGF-β1 and interstitial fibrosis in hypertensive kidney transplant patients. Am J Nephrol 2003; 23: 300-6
    • (2003) Am J Nephrol , vol.23 , pp. 300-306
    • El-Agroudy, A.E.1    Hassan, N.A.2    Foda, M.A.3
  • 24
    • 0032784820 scopus 로고    scopus 로고
    • Losartan decreases plasma levels of TGF-β1 in transplant patients with chronic allograft nephropathy
    • Campistol JM, Iñigo P, Jimenez W, et al. Losartan decreases plasma levels of TGF-β1 in transplant patients with chronic allograft nephropathy. Kidney Int 1999; 56: 714-9
    • (1999) Kidney Int , vol.56 , pp. 714-719
    • Campistol, J.M.1    Iñigo, P.2    Jimenez, W.3
  • 25
    • 0037024272 scopus 로고    scopus 로고
    • Increased transforming growth factor-beta1 circulating levels and production in human monocytes after 3-hydroxy-3-methyl-glutaryl-coenzyme A reductase inhibition with pravastatin
    • Porreca E, Febbo CD, Baccante G, et al. Increased transforming growth factor-beta1 circulating levels and production in human monocytes after 3-hydroxy-3-methyl-glutaryl-coenzyme A reductase inhibition with pravastatin. J Am Coll Cardiol 2002; 39: 1752-7
    • (2002) J Am Coll Cardiol , vol.39 , pp. 1752-1757
    • Porreca, E.1    Febbo, C.D.2    Baccante, G.3
  • 26
    • 33644874726 scopus 로고    scopus 로고
    • Angiotensin type 2 receptor is expressed in murine atherosclerotic lesions and modulates lesion evolution
    • Sales VL, Sukhova GK, Lopez-Ilasaca AL, et al. Angiotensin type 2 receptor is expressed in murine atherosclerotic lesions and modulates lesion evolution. Circulation 2005; 112: 3328-36
    • (2005) Circulation , vol.112 , pp. 3328-3336
    • Sales, V.L.1    Sukhova, G.K.2    Lopez-Ilasaca, A.L.3
  • 27
    • 0033533456 scopus 로고    scopus 로고
    • Comparison of candesartan, enalapril, and their combination in congestive heart failure: Randomized Evaluation of Strategies for Left Ventricular Dysfunction (RESOLVD) pilot study
    • The RESOLVD pilot study investigators. Comparison of candesartan, enalapril, and their combination in congestive heart failure: Randomized Evaluation of Strategies for Left Ventricular Dysfunction (RESOLVD) pilot study. Circulation 1999; 100: 1056-64
    • (1999) Circulation , vol.100 , pp. 1056-1064
  • 28
    • 0038730605 scopus 로고    scopus 로고
    • Inhibition of the renin-angiotensin system: No effect on circulating macrophage colony-stimulating factor levels in acute myocardial infarction
    • Kurosaki K, Ikeda U, Murakami Y, et al. Inhibition of the renin-angiotensin system: no effect on circulating macrophage colony-stimulating factor levels in acute myocardial infarction. J Cardiovasc Pharmacol 2003; 42: 37-41
    • (2003) J Cardiovasc Pharmacol , vol.42 , pp. 37-41
    • Kurosaki, K.1    Ikeda, U.2    Murakami, Y.3
  • 29
    • 0032849727 scopus 로고    scopus 로고
    • Systemic inflammatory parameters in patients with atherosclerosis of the coronary and peripheral arteries
    • Erren M, Reinecke H, Junker R, et al. Systemic inflammatory parameters in patients with atherosclerosis of the coronary and peripheral arteries. Arterioscler Thromb Vasc Biol 1999; 19: 2355-63
    • (1999) Arterioscler Thromb Vasc Biol , vol.19 , pp. 2355-2363
    • Erren, M.1    Reinecke, H.2    Junker, R.3
  • 30
    • 0028918825 scopus 로고
    • The serum concentration of active transforming growth factor-β is severely depressed in advanced atherosclerosis
    • Grainger DJ, Kemp PR, Metcalfe JC, et al. The serum concentration of active transforming growth factor-β is severely depressed in advanced atherosclerosis. Nat Med 1995; 1: 74-9
    • (1995) Nat Med , vol.1 , pp. 74-79
    • Grainger, D.J.1    Kemp, P.R.2    Metcalfe, J.C.3
  • 31
    • 0030994625 scopus 로고    scopus 로고
    • Circulating transforming growth factor β 1 and coronary artery disease
    • Wang XL, Liu SX, Wilcken DEL. Circulating transforming growth factor β 1 and coronary artery disease. Cardiovasc Res 1997; 34: 404-10
    • (1997) Cardiovasc Res , vol.34 , pp. 404-410
    • Wang, X.L.1    Liu, S.X.2    Wilcken, D.E.L.3
  • 32
    • 0034690805 scopus 로고    scopus 로고
    • Association of a T29 C polymorphism of the transforming growth factor-β 1 gene with genetic susceptibility to myocardial infarction in Japanese
    • Yokota M, Ichihara S, Lin TL, et al. Association of a T29 C polymorphism of the transforming growth factor-β 1 gene with genetic susceptibility to myocardial infarction in Japanese. Circulation 2000; 101: 2783-7
    • (2000) Circulation , vol.101 , pp. 2783-2787
    • Yokota, M.1    Ichihara, S.2    Lin, T.L.3
  • 33
    • 0038344675 scopus 로고    scopus 로고
    • Antiatherosclerotic effects of β-blockers
    • Wikstrand J, Berglund G, Hedblad B, et al. Antiatherosclerotic effects of β-blockers. Am J Cardiol 2003; 91 Suppl.: 25-9H
    • (2003) Am J Cardiol , vol.91 , Issue.SUPPL.
    • Wikstrand, J.1    Berglund, G.2    Hedblad, B.3
  • 34
    • 0027163945 scopus 로고
    • Carvedilol, a cardiovascular drug, prevents vascular smooth muscle cell proliferation, migration, and neointimal formation following vascular injury
    • U S A
    • Ohlstein EH, Douglas SA, Sung CP, et al. Carvedilol, a cardiovascular drug, prevents vascular smooth muscle cell proliferation, migration, and neointimal formation following vascular injury. Proc Natl Acad Sci U S A 1993; 90 (13): 6189-93
    • (1993) Proc Natl Acad Sci , vol.90 , Issue.13 , pp. 6189-6193
    • Ohlstein, E.H.1    Douglas, S.A.2    Sung, C.P.3
  • 35
    • 0842311007 scopus 로고    scopus 로고
    • Calcium channel blocker azelnidipine enhances vascular protective effects of AT1 receptor blocker olmesartan
    • Jinno T, Iwai M, Li Z, et al. Calcium channel blocker azelnidipine enhances vascular protective effects of AT1 receptor blocker olmesartan. Hypertension 2004; 43: 263-9
    • (2004) Hypertension , vol.43 , pp. 263-269
    • Jinno, T.1    Iwai, M.2    Li, Z.3
  • 36
    • 0033039589 scopus 로고    scopus 로고
    • Distinct and combined vascular effects of ACE blockade and HMG-CoA reductase inhibition in hypertensive subjects
    • Nazzaro P, Manzari M, Merlo M, et al. Distinct and combined vascular effects of ACE blockade and HMG-CoA reductase inhibition in hypertensive subjects. Hypertension 1999; 33: 719-25
    • (1999) Hypertension , vol.33 , pp. 719-725
    • Nazzaro, P.1    Manzari, M.2    Merlo, M.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.